Literature DB >> 14761185

Explorations of peptide and oligonucleotide binding sites of tyrosyl-DNA phosphodiesterase using vanadate complexes.

Douglas R Davies1, Heidrun Interthal, James J Champoux, Wim G J Hol.   

Abstract

Tyrosyl-DNA phosphodiesterase (Tdp1) catalyzes the hydrolysis of a phosphodiester bond between a tyrosine residue and a DNA 3' phosphate and functions as a DNA repair enzyme that cleaves stalled topoisomerase I-DNA complexes. We previously determined a procedure to crystallize a quaternary complex containing Tdp1, vanadate, a DNA oligonucleotide, and a tyrosine-containing peptide that mimics the transition state for hydrolysis of the Tdp1 substrate. Here, the ability of vanadate to accept a variety of different ligands is exploited to produce several different quaternary complexes with a variety of oligonucleotides, and peptides or a tyrosine analogue, in efforts to explore the binding properties of the Tdp1 DNA and peptide binding clefts. Eight crystal structures of Tdp1 with vanadate, oligonucleotides, and peptides or peptide analogues were determined. These structures demonstrated that Tdp1 is able to bind substituents with limited sequence variation in the polypeptide moiety and also bind oligonucleotides with sequence variation at the 3' end. Additionally, the tyrosine analogue octopamine can replace topoisomerase I derived peptides as the apical ligand to vanadate. The versatility of this system suggests that the formation of quaternary complexes around vanadate could be adapted to become a useful method for structure-based inhibitor design and has the potential to be generally applicable to other enzymes that perform chemistry on phosphate esters.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14761185     DOI: 10.1021/jm030487x

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  22 in total

1.  Tyrosyl-DNA phosphodiesterase (Tdp1) participates in the repair of Top2-mediated DNA damage.

Authors:  Karin C Nitiss; Mobeen Malik; Xiaoping He; Stephen W White; John L Nitiss
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-02       Impact factor: 11.205

2.  Synthesis and biological evaluation of the first dual tyrosyl-DNA phosphodiesterase I (Tdp1)-topoisomerase I (Top1) inhibitors.

Authors:  Trung Xuan Nguyen; Andrew Morrell; Martin Conda-Sheridan; Christophe Marchand; Keli Agama; Alun Bermingham; Alun Bermingam; Andrew G Stephen; Adel Chergui; Alena Naumova; Robert Fisher; Barry R O'Keefe; Yves Pommier; Mark Cushman
Journal:  J Med Chem       Date:  2012-04-26       Impact factor: 7.446

3.  Alteration of oligomeric state and domain architecture is essential for functional transformation between transferase and hydrolase with the same scaffold.

Authors:  Ryotaro Koike; Akinori Kidera; Motonori Ota
Journal:  Protein Sci       Date:  2009-10       Impact factor: 6.725

Review 4.  Recognition and repair of chemically heterogeneous structures at DNA ends.

Authors:  Sara N Andres; Matthew J Schellenberg; Bret D Wallace; Percy Tumbale; R Scott Williams
Journal:  Environ Mol Mutagen       Date:  2014-08-11       Impact factor: 3.216

5.  Human Tdp1 cleaves a broad spectrum of substrates, including phosphoamide linkages.

Authors:  Heidrun Interthal; Hong Jing Chen; James J Champoux
Journal:  J Biol Chem       Date:  2005-08-31       Impact factor: 5.157

Review 6.  Bacterial non-specific nucleases of the phospholipase D superfamily and their biotechnological potential.

Authors:  Lynn Sophie Schwardmann; Volker Nölle; Skander Elleuche
Journal:  Appl Microbiol Biotechnol       Date:  2020-02-21       Impact factor: 4.813

7.  SCAN1 mutant Tdp1 accumulates the enzyme--DNA intermediate and causes camptothecin hypersensitivity.

Authors:  Heidrun Interthal; Hong Jing Chen; Thomas E Kehl-Fie; Jörg Zotzmann; John B Leppard; James J Champoux
Journal:  EMBO J       Date:  2005-05-26       Impact factor: 11.598

8.  Design and synthesis of fluorescent substrates for human tyrosyl-DNA phosphodiesterase I.

Authors:  Marc C Rideout; Amy C Raymond; Alex B Burgin
Journal:  Nucleic Acids Res       Date:  2004-08-27       Impact factor: 16.971

9.  Inhibitors of human tyrosyl-DNA phospodiesterase (hTdp1) developed by virtual screening using ligand-based pharmacophores.

Authors:  Iwona E Weidlich; Thomas Dexheimer; Christophe Marchand; Smitha Antony; Yves Pommier; Marc C Nicklaus
Journal:  Bioorg Med Chem       Date:  2009-11-11       Impact factor: 3.641

10.  Structures of the phosphorylated and VO(3)-bound 2H-phosphatase domain of Sts-2.

Authors:  Yunting Chen; Jean Jakoncic; Kathlyn A Parker; Nick Carpino; Nicolas Nassar
Journal:  Biochemistry       Date:  2009-09-01       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.